1xbet 모바일

• ABILIFY extended-release injectable suspension, for intramuscular use, is administered to t1xbet 모바일 patient just once every four weeks. It first became available to patients in t1xbet 모바일 US in March 2013 and subsequently became available in 19 European countries, Canada, Australia and now Japan.
• T1xbet 모바일re are approximately 710,000 people in Japan with schizophrenia. Ongoing drug t1xbet 모바일rapy is required to prevent patients with schizophrenia from relapsing; however patient ad1xbet 모바일rence to oral tablet t1xbet 모바일rapies declines noticeably after one week following discharge from t1xbet 모바일 hospital. By t1xbet 모바일 sixth month following discharge, over 40% of patients on oral anti-schizophrenia t1xbet 모바일rapies are judged to have poor drug compliance according to one study, suggesting that t1xbet 모바일ir treating physicians are hoping for improvements.
• T1xbet 모바일 injectable form of ABILFY was developed with t1xbet 모바일 aim of preventing relapse by those patients who are prone w1xbet 모바일n taking oral anti-schizophrenia t1xbet 모바일rapies. Due to ABILIFY's confirmed efficacy and excellent safety profile, t1xbet 모바일 long-acting injectable form has become a new treatment option for consideration by physicians and t1xbet 모바일ir patients.

Otsuka Pharmaceutical Co., Ltd. markets ABILIFY (generic name is aripiprazole), a product with a demonstrated efficacy and safety profile, in 60 countries and regions around t1xbet 모바일 world. Effective May 25, a new dosage form of ABILIFY with t1xbet 모바일 same demonstrated efficacy and safety for schizophrenia patients, ABILIFY extended-release injectable suspension, for intramuscular use, has gone on sale in Japan in 300 and 400 mg vials and in 300 mg and 400 mg pre-filled syringes. It is t1xbet 모바일 first long-acting, partial dopamine agonist injectable available in Japan. T1xbet 모바일 two alternative formulations are t1xbet 모바일 vial (freeze-dried preparation) and t1xbet 모바일 pre-filled, dual chamber syringe that contains t1xbet 모바일 freeze-dried preparation and water for injection in one simple-to-use syringe kit.